Yuri Teranishi

Title: Innovations of Inventor Yuri Teranishi

Introduction

Yuri Teranishi is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. With a total of four patents to his name, Teranishi's work has the potential to impact medical treatments significantly.

Latest Patents

One of Teranishi's latest patents involves bispecific antibodies that bind to blood coagulation factor VIII and exhibit enhanced activity. This innovation is particularly relevant for treating bleeding and associated conditions. The inventors discovered ACE910 variants with modifications in various sites of the constant regions, leading to bispecific antibodies with FVIII mimetic activity that surpasses that of ACE910. Additionally, they identified mutation positions that enhance FVIII mimetic activity and developed methods to elevate this activity through these mutations. Another significant patent is for an anti-Plexin A1 agonist antibody, which promotes dendritic cell contraction. This invention also includes a pharmaceutical composition that comprises the antibody and a pharmaceutically acceptable carrier.

Career Highlights

Throughout his career, Teranishi has worked with prominent organizations such as Chugai Seiyaku Kabushiki Kaisha and Osaka University. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research.

Collaborations

Some of Teranishi's notable coworkers include Tomoyuki Igawa and Atsushi Kumanogoh. Their collaborative efforts have contributed to the advancements in the research and development of innovative therapies.

Conclusion

Yuri Teranishi's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work on bispecific antibodies and anti-Plexin A1 agonist antibodies showcases the potential for innovative treatments in medicine.